399 related articles for article (PubMed ID: 24749386)
21. Evaluation of the cytotoxic effects of PLGA coated iron oxide nanoparticles as a carrier of 5- fluorouracil and mega-voltage X-ray radiation in DU145 prostate cancer cell line.
Hajikarimi Z; Khoei S; Khoee S; Mahdavi SR
IEEE Trans Nanobioscience; 2014 Dec; 13(4):403-8. PubMed ID: 25051558
[TBL] [Abstract][Full Text] [Related]
22. Enhanced Intracellular Hyperthermia Efficiency by Magnetic Nanoparticles Modified with Nucleus and Mitochondria Targeting Peptides.
Wang X; Zhou J; Chen B; Tang Z; Zhang J; Li L; Tang J
J Nanosci Nanotechnol; 2016 Jun; 16(6):6560-6. PubMed ID: 27427753
[TBL] [Abstract][Full Text] [Related]
23. Real-time near-infrared bioimaging of a receptor-targeted cytotoxic dendritic theranostic agent.
Wu J; Zhou Y; Li S; Qu D; Zhu WH; Tian H
Biomaterials; 2017 Mar; 120():1-10. PubMed ID: 28011190
[TBL] [Abstract][Full Text] [Related]
24. Polyethylene glycol-coated porous magnetic nanoparticles for targeted delivery of chemotherapeutics under magnetic hyperthermia condition.
Dabbagh A; Hedayatnasab Z; Karimian H; Sarraf M; Yeong CH; Madaah Hosseini HR; Abu Kasim NH; Wong TW; Rahman NA
Int J Hyperthermia; 2019; 36(1):104-114. PubMed ID: 30428737
[TBL] [Abstract][Full Text] [Related]
25. Magnetic nanoparticles-based drug and gene delivery systems for the treatment of pulmonary diseases.
El-Sherbiny IM; Elbaz NM; Sedki M; Elgammal A; Yacoub MH
Nanomedicine (Lond); 2017 Feb; 12(4):387-402. PubMed ID: 28078950
[TBL] [Abstract][Full Text] [Related]
26. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
[TBL] [Abstract][Full Text] [Related]
27. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
[TBL] [Abstract][Full Text] [Related]
28. Tumor targeting by lentiviral vectors combined with magnetic nanoparticles in mice.
Borroni E; Miola M; Ferraris S; Ricci G; Žužek Rožman K; Kostevšek N; Catizone A; Rimondini L; Prat M; Verné E; Follenzi A
Acta Biomater; 2017 Sep; 59():303-316. PubMed ID: 28688987
[TBL] [Abstract][Full Text] [Related]
29. Magnetic Nanoparticles: A Review on Stratagems of Fabrication an d its Biomedical Applications.
Srivastava P; Sharma PK; Muheem A; Warsi MH
Recent Pat Drug Deliv Formul; 2017; 11(2):101-113. PubMed ID: 28355997
[TBL] [Abstract][Full Text] [Related]
30. A novel magnetic nanoparticle hyperthermia combined with ACMF-dependant drug release by DAMMs injection in VX-2 liver tumors.
Zhang Q; Tong J; Chen H; Jiang L; Zhu H; Zhu X; Yu H; Liu J; Liu B
J Nanosci Nanotechnol; 2012 Jan; 12(1):127-31. PubMed ID: 22523955
[TBL] [Abstract][Full Text] [Related]
31. Magnetic nanoparticles applied in targeted therapy and magnetic resonance imaging: crucial preparation parameters, indispensable pre-treatments, updated research advancements and future perspectives.
Lin Y; Zhang K; Zhang R; She Z; Tan R; Fan Y; Li X
J Mater Chem B; 2020 Jul; 8(28):5973-5991. PubMed ID: 32597454
[TBL] [Abstract][Full Text] [Related]
32. Combination of selol nanocapsules and magnetic hyperthermia hinders breast tumor growth in aged mice after a short-time treatment.
Pinheiro WO; Costa do Santos MS; Farias GR; Fascineli ML; Ramos KLV; Duarte ECB; Damasceno EAM; da Silva JR; Joanitti GA; de Azevedo RB; Sousa MH; Lacava ZGM; Mosiniewicz-Szablewska E; Suchocki P; Morais PC; de Andrade LR
Nanotechnology; 2022 Feb; 33(20):. PubMed ID: 35100566
[TBL] [Abstract][Full Text] [Related]
33. Chitosan oligosaccharide-stabilized ferrimagnetic iron oxide nanocubes for magnetically modulated cancer hyperthermia.
Bae KH; Park M; Do MJ; Lee N; Ryu JH; Kim GW; Kim C; Park TG; Hyeon T
ACS Nano; 2012 Jun; 6(6):5266-73. PubMed ID: 22588093
[TBL] [Abstract][Full Text] [Related]
34. Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy.
Gogoi M; Jaiswal MK; Sarma HD; Bahadur D; Banerjee R
Integr Biol (Camb); 2017 Jun; 9(6):555-565. PubMed ID: 28513646
[TBL] [Abstract][Full Text] [Related]
35. Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia.
Balasubramanian S; Girija AR; Nagaoka Y; Iwai S; Suzuki M; Kizhikkilot V; Yoshida Y; Maekawa T; Nair SD
Int J Nanomedicine; 2014; 9():437-59. PubMed ID: 24531392
[TBL] [Abstract][Full Text] [Related]
36. Polymer Stabilized Fe3O4-Graphene as an Amphiphilic Drug Carrier for Thermo-Chemotherapy of Cancer.
Swain AK; Pradhan L; Bahadur D
ACS Appl Mater Interfaces; 2015 Apr; 7(15):8013-22. PubMed ID: 25821899
[TBL] [Abstract][Full Text] [Related]
37. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
38. Multifunctional magnetic co-delivery system coated with polymer mPEG-PLL-FA for nasopharyngeal cancer targeted therapy and MR imaging.
Li H; Fu C; Miao X; Li Q; Zhang J; Yang H; Liu T; Chen X; Xie M
J Biomater Appl; 2017 Mar; 31(8):1169-1181. PubMed ID: 28185478
[TBL] [Abstract][Full Text] [Related]
39. Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines.
Alvarez-Berríos MP; Castillo A; Rinaldi C; Torres-Lugo M
Int J Nanomedicine; 2014; 9():145-53. PubMed ID: 24379665
[TBL] [Abstract][Full Text] [Related]
40. Effective magnetic hyperthermia induced by mitochondria-targeted nanoparticles modified with triphenylphosphonium-containing phospholipid polymers.
Kaneko M; Yamazaki H; Ono T; Horie M; Ito A
Cancer Sci; 2023 Sep; 114(9):3750-3758. PubMed ID: 37409483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
